West Nova News

Inova’s Multidisciplinary AFib Center Improves Patient Outcomes and Satisfaction

Atrial fibrillation (AFib) is the most common arrhythmia worldwide. According to the Centers for Disease Control and Prevention, an estimated 12.1 million people in the United States will have AFib by 2030. People with AFib have a risk of stroke that is five times higher than patients without AFib, and AFib causes about one out of every seven strokes. AFib can also lead to other heart-related complications.

The conditions that cause AFib are complex, and so is the management of this condition. Risk factors for AFib include age, high blood pressure, obesity, diabetes, heart failure, hyperthyroidism, alcohol use and sleep apnea. A multidisciplinary strategy not only offers  convenience for the patient, but it also fosters better collaboration for the care team and results in efficiencies that help ensure faster access to essential treatments.

The Inova AFib Center is based on a “center of excellence” model offering streamlined evaluations with medical providers from multiple specialties in one visit in the same location, followed by comprehensive, team-based care. Depending on individual risk factors and existing provider relationships, patients may be seen by specialists in general cardiology, electrophysiology, weight loss, behavioral health, sleep medicine and clinical pharmacy.

Early studies show that this approach to AFib care has been associated with reductions in all-cause mortality, cardiovascular hospitalizations and emergency room visits. Additional benefits include significantly shorter wait times to see an electrophysiologist, more cost-effective care, fewer readmissions and shorter hospital stays.

The Inova AFib Center partners with our patients, cardiologists and primary care providers to fully address the patient’s needs at various stages of treatment, using evidence-based protocols to assure delivery of high quality, state-of-the-art care. We offer patients a full range of treatment options based on their unique needs, including the latest techniques, less invasive treatments, personalized medication and emerging therapies through clinical trial partnerships. The team focuses on four specific treatment goals or pillars of AFib management:  managing risk factors, preventing stroke, controlling heart rhythm and controlling heart rate.

Original source can be found here